NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018.


Journal Article

The NCCN Guidelines for Neuroendocrine and Adrenal Tumors provide recommendations for the management of adult patients with neuroendocrine tumors (NETs), adrenal gland tumors, pheochromocytomas, and paragangliomas. Management of NETs relies heavily on the site of the primary NET. These NCCN Guidelines Insights summarize the management options and the 2018 updates to the guidelines for locoregional advanced disease, and/or distant metastasis originating from gastrointestinal tract, bronchopulmonary, and thymus primary NETs.

Full Text

Cited Authors

  • Shah, MH; Goldner, WS; Halfdanarson, TR; Bergsland, E; Berlin, JD; Halperin, D; Chan, J; Kulke, MH; Benson, AB; Blaszkowsky, LS; Eads, J; Engstrom, PF; Fanta, P; Giordano, T; He, J; Heslin, MJ; Kalemkerian, GP; Kandeel, F; Khan, SA; Kidwai, WZ; Kunz, PL; Kuvshinoff, BW; Lieu, C; Pillarisetty, VG; Saltz, L; Sosa, JA; Strosberg, JR; Sussman, CA; Trikalinos, NA; Uboha, NA; Whisenant, J; Wong, T; Yao, JC; Burns, JL; Ogba, N; Zuccarino-Catania, G

Published Date

  • June 2018

Published In

Volume / Issue

  • 16 / 6

Start / End Page

  • 693 - 702

PubMed ID

  • 29891520

Pubmed Central ID

  • 29891520

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

International Standard Serial Number (ISSN)

  • 1540-1405

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2018.0056


  • eng